Protease Inhibitor Market Outlook, Segmentation and Growth Prospect 2017-2022
Protease inhibitors (PIs) are a class of antiviral drugs that are widely used to treat HIV/AIDS and hepatitis C. Protease inhibitors prevent viral replication selectively binding to viral proteases and blocking proteolytic cleavage of protein precursors that are necessary for the production of infectious viral particles. Protease inhibitors bind to the active site of the protease enzyme and prevent the maturation of the newly produced virions so that they remain non-infectious.
Protease inhibitors (PIs) are a class of antiviral drugs that are widely used to treat HIV/AIDS and hepatitis C. Protease inhibitors prevent viral replication selectively binding to viral proteases and blocking proteolytic cleavage of protein precursors that are necessary for the production of infectious viral particles. Protease inhibitors bind to the active site of the protease enzyme and prevent the maturation of the newly produced virions so that they remain non-infectious.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Protease</strong> <strong>Inhibitor</strong> <strong>Market</strong> <strong>Outlook</strong>,<br />
<strong>Segmentation</strong> <strong>and</strong> <strong>Growth</strong> <strong>Prospect</strong> <strong>2017</strong>-<br />
<strong>2022</strong><br />
“Factors such as rising incidences of HIV, Aids <strong>and</strong> immune<br />
related problems propelled the market growth in the<br />
predicted period. Also, the rise in medical infrastructure <strong>and</strong><br />
rise in diagnostic measures also contributed to the market<br />
growth.”<br />
Global protease inhibitor market, on the basis of geography, is segmented into Asia Pacific, Latin America, Europe,<br />
North America <strong>and</strong> Middle East & Africa. <strong>Protease</strong> inhibitors (PIs) are a class of antiviral drugs that are widely used to<br />
treat HIV/AIDS <strong>and</strong> hepatitis C. <strong>Protease</strong> inhibitors prevent viral replication selectively binding to viral proteases <strong>and</strong><br />
blocking proteolytic cleavage of protein precursors that are necessary for the production of infectious viral particles.<br />
<strong>Protease</strong> inhibitors bind to the active site of the protease enzyme <strong>and</strong> prevent the maturation of the newly produced<br />
virions so that they remain non-infectious. <strong>Protease</strong> inhibitors are used in the treatment of human immunodeficiency<br />
virus (HIV infection) <strong>and</strong> acquired immune deficiency syndrome (AIDS).In addition, there are many more proteases<br />
found in viruses, bacteria <strong>and</strong> parasites which are also potential drug targets.<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/protease-inhibitor-pi-market<br />
Factors such as rising incidences of HIV, Aids <strong>and</strong> immune related problems propelled the market growth in the<br />
predicted period. Also, the rise in medical infrastructure <strong>and</strong> rise in diagnostic measures also contributed to the market
growth. <strong>Protease</strong>s comprise drug targets for HIV <strong>and</strong> the clotting cascade as well as degradative enzymes such as<br />
elastase <strong>and</strong> dipeptidyl peptidases such as DPP IV. Many viral, bacterial <strong>and</strong> parasitic proteases are also potential drug<br />
targets <strong>and</strong> due to their lower homology to their mammalian orthologs, offer target opportunities to identify selective<br />
inhibitors that have minimal cross-reactivity with mammalian proteases.<br />
Geographically, the global protease inhibitor market spans North America, Latin America, Europe, Asia-Pacific,<br />
Middle-East & Africa. North America dominated the global market owing to rising prevalence of AIDS <strong>and</strong> immune<br />
related problems. APAC market also anticipated in significant growth in the global market owing The key players in<br />
the protease inhibitor market include CSL Ltd., Grifols S.A, Baxalta Incorporated, Octapharma AG, Kedrion S.p.A,<br />
China Biologic Products Inc., Biotest AG, LFB S.A, Bio Product Laboratory Ltd. <strong>and</strong> Sanquin.<br />
Get a Sample Copy of This Report @<br />
https://www.millioninsights.com/industry-reports/protease-inhibitor-pi-market/request-sample<br />
<strong>Market</strong> Segment:<br />
Geographically, this report is segmented into several key Regions, with production, consumption, revenue<br />
(million USD), market share <strong>and</strong> growth rate of <strong>Protease</strong> <strong>Inhibitor</strong>s in these regions, from 2012 to <strong>2022</strong> (forecast),<br />
covering<br />
• North America<br />
• Europe<br />
• China<br />
• Japan<br />
• Southeast Asia<br />
• India<br />
Global <strong>Protease</strong> <strong>Inhibitor</strong>s market competition by top manufacturers, with production, price, revenue (value)<br />
<strong>and</strong> market share for each manufacturer; the top players including<br />
• CSL Ltd. (Australia)<br />
• Grifols S.A (Spain)<br />
• Baxalta Incorporated (U.S.)<br />
• Octapharma AG (Switzerl<strong>and</strong>)<br />
• KedrionS.p.A (Italy)
• China Biologic Products, Inc. (China)<br />
• Biotest AG (Germany)<br />
• LFB S.A (France)<br />
• Bio Product Laboratory Ltd. (U.K.)<br />
• Sanquin (Netherl<strong>and</strong>s)<br />
See More Reports of This Category by Million Insights @<br />
https://www.millioninsights.com/industry/generic-drugs<br />
On the basis of product, this report displays the production, revenue, price, market share <strong>and</strong> growth rate of<br />
each type, primarily split into<br />
• Reagent grade<br />
• Pharmaceutical<br />
• Grade other<br />
On the basis on the end users/applications, this report focuses on the status <strong>and</strong> outlook for major<br />
applications/end users, consumption (sales), market share <strong>and</strong> growth rate of <strong>Protease</strong> <strong>Inhibitor</strong>s for each<br />
application, including<br />
• Biotechnology<br />
• Medicine<br />
• Microbiology<br />
• Agriculture<br />
• Pharmaceuticals<br />
• Food additives<br />
• Cosmetics<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/protease-inhibitor-pi-market
Get in touch<br />
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.<br />
Our representatives strive to underst<strong>and</strong> diverse client requirements <strong>and</strong> cater to the same with the<br />
most innovative <strong>and</strong> functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research Support Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Felton Office Plaza 6265 Highway 9<br />
Felton, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikch<strong>and</strong><br />
Galleria, Model Colony, Shivaji Nagar,<br />
Pune, MH, 411016 India<br />
Phone: 91-20-65300184<br />
Email: sales@millioninsights.com<br />
Visit Our Blog: www.millioninsights.blogspot.com
Change language